Labeling may differ between generic, brand-name products

被引：2
|
作者：
Traynor, K
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2002年 / 59卷 / 10期
关键词：
D O I：
10.1093/ajhp/59.10.912
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：912 / +
页数：2
相关论文
共 50 条
  • [41] Generic versus brand-name drugs used in cardiovascular diseases
    Lamberto Manzoli
    Maria Elena Flacco
    Stefania Boccia
    Elvira D’Andrea
    Nikola Panic
    Carolina Marzuillo
    Roberta Siliquini
    Walter Ricciardi
    Paolo Villari
    John P. A. Ioannidis
    European Journal of Epidemiology, 2016, 31 : 351 - 368
  • [42] Generic versus brand-name cardiovascular drugs: a remarkable update
    Flacco, Maria Elena
    Fragassi, Giorgia
    Manzoli, Lamberto
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2015, 12 (04)
  • [43] Converting patients from brand-name clozapine to generic clozapine
    Sajbel, TA
    Carter, GW
    Wiley, RB
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (03) : 281 - 284
  • [44] Continuing trends in US brand-name and generic drug competition
    Grabowski, Henry
    Long, Genia
    Mortimer, Richard
    Bilginsoy, Mehmet
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 908 - 917
  • [45] Response of Behcet's syndrome to brand-name but not generic tetracycline
    Cohen, JB
    Bergstresser, PR
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1997, 22 (03) : 159 - 160
  • [46] Differences in fluidity and viscosity of brand-name and generic injectable ointment
    Ishimura, Atsushi
    Ogawa, Chiaki
    Yatabe, Megumi
    Tani, Kentaro
    Inoue, Motoki
    DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (04): : 265 - 268
  • [47] GENERIC AND ALTERNATIVE BRAND-NAME PHARMACEUTICAL EQUIVALENTS - SELECT WITH CAUTION
    HENDELES, L
    HOCHHAUS, G
    KAZEROUNIAN, S
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (02): : 323 - 329
  • [48] "Real World" Difference in Effectiveness between Brand-Name and Generic Drugs - Real? or Fantasy?
    Wu, Yih-Jer
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2019, 13 (02) : 105 - 105
  • [49] Brand-name buildup
    Rutledge, J
    FORBES, 1997, 160 (12): : 72 - 72
  • [50] Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act
    Grabowski, Henry G.
    Kyle, Margaret
    Mortimer, Richard
    Long, Genia
    Kirson, Noam
    HEALTH AFFAIRS, 2011, 30 (11) : 2157 - 2166
12345